In Vitro Immunomodulatory Properties of Tucaresol in HIV Infection

This publication has 24 references indexed in Scilit:

• Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
  The Journal of Infectious Diseases, 1999
• Determinants of the Natural History of Human Immunodeficiency Virus Type 1 Infection
  The Journal of Infectious Diseases, 1999
• Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy
  New England Journal of Medicine, 1998
• Host factors and the pathogenesis of HIV-induced disease
  Nature, 1996
• Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
  The Journal of Infectious Diseases, 1996
• Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs
  Nature, 1995
• Shutting down HIV
  Nature, 1994
• Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
  Journal of Clinical Investigation, 1989
• Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
  Nature, 1989
• Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
  Journal of Clinical Investigation, 1988